Outlook Therapeutics, Inc. · NASDAQ:OTLK

Outlook Therapeutics, Inc. shareholders

As of Jun 30, 2026, 66 institutions reported holding Outlook Therapeutics, Inc., 8.4% of its shares. Largest: Vanguard, Perceptive Advisors LLC and Marshall Wace, LLP. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Outlook Therapeutics, Inc.ChangeFiled
Vanguard5.1M2.1%+2.92MAug 13, 2026
Perceptive Advisors LLC3.14M1.3%newAug 14, 2026
Marshall Wace, LLP1.99M0.82%newAug 13, 2026
BlackRock1.67M0.69%+1.19MAug 7, 2026
Jane Street1.43M0.59%newAug 14, 2026
Geode Capital1.25M0.51%+642KAug 12, 2026
Susquehanna968K0.40%+834KAug 14, 2026
Hrt Financial LP785K0.32%+717KAug 14, 2026
Gilpin Wealth Management, LLC555K0.23%−45,162Jul 24, 2026
State Street540K0.22%+377KAug 7, 2026

Outlook Therapeutics, Inc. insider trades